Here are the UK’s top-paid FTSE 100 CEOs — as report finds exec salaries at record high

Here are the UK’s top-paid FTSE 100 CEOs — as report finds exec salaries at record high


The City of London skyline at sunset.

Gary Yeowell | Digitalvision | Getty Images

The bosses of Britain’s biggest listed companies took home record salaries in the latest financial year, according to a new report.

Median pay among FTSE 100 chief executive officers was £4.58 million ($6.2 million) in the year to March 31, the High Pay Centre found — up from £4.29 million in the 2023-2024 financial year and the highest figure since companies have been required to disclose a single figure for CEO pay, in 2013.

Mean bonus payments meanwhile increase to £1.61 million from £1.48 million, the think tank said.

CNBC has not independently verified the figures in the report. The High Pay Centre’s report does not include privately-held companies, meaning it does not reflect all of the the U.K.’s top earners.

The average U.K. full-time worker earned £37,430 last year, or 122 times less than the typical FTSE 100 chief. That gap is even higher in the U.S., where the bosses of the biggest listed companies made around 290 times that of the average worker in 2023, according to a report from the Economic Policy Institute.

No women feature in this year’s list of top 10 FTSE 100 earners. The High Pay Centre said a total of nine female CEOs served for the entire financial year across the index, with median pay of £3.27 million, below the £4.64 million for companies run for the full year by a man.

The U.K.’s highest-paid female executive is widely understood to be Denise Coates, head of online gambling firm Bet365 Group, whose salary totaled £94.66 million last year, according to company accounts.

Since 2019, London-listed companies with over 250 employees have had to disclose the ratio between the pay of their CEO and their average worker and make disclosures to justify the salaries of top bosses.

Using this “single figure” disclosure, which typically includes base salary, bonus, pension, and short- and long-term performance incentives, the highest-paid CEOs in the U.K. were:

Highest salaries among FTSE 100 CEOs

Company Sector CEO Pay 2024-25 (£m)
Melrose Industries Aerospace Simon Peckham/Peter Dilnot* 58.9
Pearson Education Andy Bird/Omar Abbish* 18.9
AstraZeneca Pharmaceuticals Pascal Soriot 14.7
Coca-Cola Europacific Partners Consumer Goods Damian Gammell 13.9
Relx Data Analytics Erik Engstrom 13.5
3i Private equity Simon Borrows 11.9
BAE Systems Defense Charles Woodburn 11.7
HSBC Banking Noel Quinn/Georges Elhedery* 11
Standard Chartered Banking Bill Winters 10.7
Experian Financial Services Brian Cassin 10.6
*Annual rate calculated from two figures where role changed hands, including one-off payments

Source: High Pay Centre



Source

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World
World

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, bitcoin falls as Wall Street rethinks some AI investments. Also, CF Benchmarks CEO Sui Chung discusses recent trends in crypto ETFs. Source

Read More
The chart that has Michael Burry worried about the stock market
World

The chart that has Michael Burry worried about the stock market

Michael Burry is warning that a shift in household wealth could leave the stock market vulnerable to a long and significant downturn. “The Big Short” investor pointed to a graphic produced by Wells Fargo showing that U.S. households now hold a larger share of their net worth in equities than in real estate — a […]

Read More
This biotech name is evolving into a major obesity play. How to trade it with options
World

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra […]

Read More